Hyaluronic acid is a glycosaminoglycan polymer, which is commonly found in an extracellular matrix of vertebrate epithelial, connective & neural tissues. It plays a vital role in various signaling pathways in the human body for instance wound healing, cancer treatment, embryonic development, and inflammation. Its type & functioning depends upon the chain length or molecular weight of the hyaluronic acid which is used in making the product. High molecular weight hyaluronic acid is used in opthalmology, tissue engineering, orthopedic products, and in the making of cosmetics, while low molecular weight hyaluronic acid is employed in the production of substances which induce expression of pro-inflammatory products & inhibit the tumor progression in body. It is found to be ubiquitously spread in numerous parts of vertebrate tissues with differing molecular weight & concentrations, which includes brain, umbilical cord, and synovial fluid present between neural tissues, rooster comb, joints, epithelium, and skin. It is processed either from bacterium or rooster comb called ‘Streptococcus’.
According to study, “World Hyaluronic Acid Market Research Report 2024(covering USA, EU, China, South East Asia, Japan and etc)” the key companies operating in the world hyaluronic acid market are Q-Med, Lipo Chemicals, Abbott Medical Optics, Stanford Chemicals, Anika Therapeutics, Allergan Inc., Novozymes, LG Life & Science, Hyaltech, Medicis Aesthetics Holdings, Inc., Seikagaku, Shiseido, CONTIPRO, Genzyme Biosurgery, Synvisc-One, Ferring Pharmaceuticals Inc., Sanofi, Merz Pharmaceuticals, Paiho Group, Bausch+Lomb, Hao Hai Healthcare, Shanghai Jingfeng, F.hoffmann-la Roche Ltd., Smith & Nephew Plc., Salix Pharmaceuticals, Zimmer Biomet. Key companies are trying to collaborate with universities & other research organizations for research activities, which would lead them for high product innovations precise to the end-user application and help them to increase the market by volume.
Based on type, hyaluronic acid market is segmented into single injection type, three injection type and five injection type. Single-injection segment is projected to be the fastest-growing segment owing to high preference for short treatment duration & quick results. Based on nature, market is segmented into conventional nature and organic nature. Based on sales channel, market is segmented into business to business (B2B) and business to customer (B2C). B2C is further sub-segmented into hypermarket/supermarket, specialty stores and online stores. Based on application, market is segmented into wound healing, cushioning, eye-surgical operation, pain killer, moisturizers, anti-ageing creams, lubrication, veterinary, sun protect, plastic-surgery injections, dietary supplement and additive. In addition, based on end-use industries, market is segmented into cosmetic industry, food industry, medical industry and others.
The hyaluronic acid market is driven by increase in skin & orthopedic problems among the individuals, followed by rise in interest from beauty care products & therapeutic application increase in disposable income, growth in use of orthopedic products, rise in concern about toxic chemicals, increase in number of cosmetic surgeries and rise in incidence of diseases, such as age-related macular degeneration, glaucoma, cataracts, and dry eyes. However, cost-friendly alternatives and allergic reactions caused owing to consumption of hyaluronic acid may impact the market.
Based on geography, the USA country holds major share, followed by EU in hyaluronic acid market owing to quick adoption of new technologies & treatment methods and high health awareness among individuals in the country. The China country is expected to witness higher growth rate due to rise in geriatric population and increase in awareness about aesthetic over the forecast period.
For More Information on the research report, refer to below link:-
Ankur Gupta, Head Marketing & Communications